Form 4 for RGEN REPLIGEN CORP

Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-14 · accession 0000950170-24-073858 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-06-14	2024-06-14	RGEN	Madaus Martin D	Dir	P - Purchase	$124.94	+1,615	4,613	+54%	+$201.8K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-06-14	P	A	915	$124.54	3,913	D	—	—	(F1) $124.54 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $124.25 to $125.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range. (F3) Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.
2	Common	Common Stock	2024-06-14	P	A	700	$125.46	4,613	D	—	—	(F2) $125.46 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $125.25 to $125.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range. (F3) Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.